Skip to content
buyWeak

Opaleye Management Inc. bought $16k of GRCE

owner at Acasti Pharma Inc.. 7,849 shares at an average of $2.09, traded Sep 29, 2026, filed Oct 1, 2026.

Conviction score
25
Value
$16k
7,849 shares
Holdings after
2,798,167
+0% from before
From 52-week low
+2%
low $2.07, close $2.11
From 52-week high
-59%
high $5.13, as of Sep 29, 2026

Score components

  • Role
    10% owner
    +12
  • Trade size
    $16k at market
    0
  • Relative to holdings
    Under 1% of holdings (0.3%)
    -5
  • Price context
    2% above the 52-week low; 59% below the 52-week high
    +18
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    4 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (0 with prices)
    0
  • Outside holder
    A 10% owner who is not an officer or director
    -5

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

GRCEOct 12, 2026 · close 2.02
Since filing Oct 1, 2026: -1.0%SPY +1.8% · excess -2.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-26-045358, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 29, 2026POpen-market purchase
Common Stock, par value $0.0001 per shareindirect: By Opaleye, L.P.
+7,849$2.09$16k2,798,16713 d ago

Related signals

Other insiders at Acasti Pharma Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
40Moderate
GRCEbuy
Acasti Pharma Inc.
Opaleye Management Inc.
owner
$124k
60,490 shares
+2%
38Weak
GRCEbuy 2
Acasti Pharma Inc.
Opaleye Management Inc.
owner
$32k
15,089 shares
+1%
38Weak
GRCEbuy 2
Acasti Pharma Inc.
Opaleye Management Inc.
owner
$32k
15,089 shares
+1%
73Notable
GRCEbuy 2
Acasti Pharma Inc.
Prashant Kohli
Chief Executive Officer
$214k
100,000 shares
+468%
33Weak
GRCEbuy 2
Acasti Pharma Inc.
Opaleye Management Inc.
owner
$32k
15,229 shares
+1%
25Weak
GRCEbuy
Acasti Pharma Inc.
Opaleye Management Inc.
owner
$24k
11,608 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Opaleye Management Inc. bought $16k of GRCE | InsiderTell